Your browser doesn't support javascript.
loading
Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial.
Murphy, Sean M; Campbell, Aimee N C; Ghitza, Udi E; Kyle, Tiffany L; Bailey, Genie L; Nunes, Edward V; Polsky, Daniel.
Afiliação
  • Murphy SM; Department of Health Policy and Administration, Washington State University, Spokane, WA, USA. Electronic address: sean.murphy@wsu.edu.
  • Campbell AN; New York State Psychiatric Institute, Department of Psychiatry, Columbia University, New York, NY, USA.
  • Ghitza UE; Center for the Clinical Trials Network, National Institute on Drug Abuse, Bethesda, MD, USA.
  • Kyle TL; Aspire Health Partners, Orlando, FL, USA.
  • Bailey GL; Department of Psychiatry and Human Behavior, Brown University, Providence, RI, USA; Stanley Street Treatment and Resources, Fall River, MA, USA.
  • Nunes EV; New York State Psychiatric Institute, Department of Psychiatry, Columbia University, New York, NY, USA.
  • Polsky D; Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA.
Drug Alcohol Depend ; 161: 119-26, 2016 Apr 01.
Article em En | MEDLINE | ID: mdl-26880594
ABSTRACT

BACKGROUND:

Substance misuse and excessive alcohol consumption are major public health issues. Internet-based interventions for substance use disorders (SUDs) are a relatively new method for addressing barriers to access and supplementing existing care. This study examines cost-effectiveness in a multisite, randomized trial of an internet-based version of the community reinforcement approach (CRA) with contingency management (CM) known as the Therapeutic Education System (TES).

METHODS:

Economic evaluation of the 12-week trial with follow-up at 24 and 36 weeks. 507 individuals who were seeking therapy for alcohol or other substance use disorders at 10 outpatient community-based treatment programs were recruited and randomized to either treatment as usual (TAU) or TES+TAU. Sub-analyses were completed on participants with a poorer prognosis (i.e., those not abstinent at study entry).

RESULTS:

From the provider's perspective, TES+TAU as it was implemented in this study costs $278 (SE=87) more than TAU alone after 12 weeks. The quality-adjusted life years gained by TES+TAU and TAU were similar; however, TES+TAU has at least a 95% chance of being considered cost-effective for providers and payers with willingness-to-pay thresholds as low as $20,000 per abstinent year. Findings for the subgroup not abstinent at study entry are slightly more favorable.

CONCLUSIONS:

With regard to the clinical outcome of abstinence, our cost-effectiveness findings of TES+TAU compare favorably to those found elsewhere in the CM literature. The analyses performed here serve as an initial economic framework for future studies integrating technology into SUD therapy.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Comportamental / Análise Custo-Benefício / Transtornos Relacionados ao Uso de Substâncias / Internet Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Drug Alcohol Depend Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Comportamental / Análise Custo-Benefício / Transtornos Relacionados ao Uso de Substâncias / Internet Tipo de estudo: Clinical_trials / Health_economic_evaluation / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Drug Alcohol Depend Ano de publicação: 2016 Tipo de documento: Article